Institute of Mental Health

imh.com.sg

The Institute of Mental Health (IMH) is a 2,000-bed acute tertiary psychiatric hospital situated on a 23-hectare campus at Buangkok Green Medical Park. Set amidst serene surroundings, IMH offers a comprehensive range of psychiatric, rehabilitative and counselling services for children, adolescents, adults, and the elderly.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

METASTASIS BLOCKING ANTIBODY SHOWS PRECLINICAL PROMISE

Genetic Engineering and Biotechnology News | April 24, 2020

news image

Investigators at the German Cancer Research Center in Heidelberg (DKFZ) and the Mannheim Medical Faculty of the University of Heidelberg have released data on an antibody they created that blocks a receptor that stimulates the formation of new blood vessels in tumors and metastasis. Findings from the new stud—published recently in EMBO Molecular Medicine through an article entitled “Preclinical validation of a novel metastasis‐inhibiting Tie1 function‐blocking antibody”—s...

Read More

CELL AND GENE THERAPY

MISSION BIO DEVELOPS SINGLE-CELL SOLUTION TO ADDRESS CHALLENGES IN GENOME EDITING

PR Newswire | May 12, 2023

news image

Mission Bio, the single-cell DNA and multi-omics company, announced today the Tapestri® Genome Editing Solution, an end-to-end product for genome editing analysis. The product will be previewed next week at the American Society of Gene and Cell Therapy Conference (ASGCT) 26th Annual Meeting. By enabling robust single-cell insights impacting both efficacy and safety, the solution will be a powerful analytical tool for developing the next generation of gene-edited therapies. T...

Read More

DIAGNOSTICS

MERIDIAN LAUNCHES NEW QPCR MASTER MIXES FOR STOOL SAMPLES TO ACCELERATE DEVELOPMENT OF MOLECULAR ASSAYS

Meridian | June 21, 2022

news image

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today two new sample-specific master mixes, Lyo-Ready™ Direct DNA qPCR Stool Mix, and Lyo-Ready™ Direct RNA/DNA qPCR Stool Mix. These innovative master mixes improve the molecular detection of DNA and RNA from crude fecal specimens while allowing room temperature stabilization of diagnostic assays. Stool samples are used in many ...

Read More

INDUSTRY OUTLOOK

ANDELYN BIOSCIENCES SELECTS TETRASCIENCE AS A STRATEGIC PARTNER FOR INNOVATION IN THERAPEUTICS DEVELOPMENT AND MANUFACTURING

Andelyn Biosciences | August 26, 2021

news image

TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers. As part of an Andelyn Biosciences initiative to create a Connected Plant that harmonizes data from building and facilities, process and manufacturing, and lab instrument sources, TDP will enable better compliance, easier analysis, faster decisions, and more agile operations. Additio...

Read More
news image

METASTASIS BLOCKING ANTIBODY SHOWS PRECLINICAL PROMISE

Genetic Engineering and Biotechnology News | April 24, 2020

Investigators at the German Cancer Research Center in Heidelberg (DKFZ) and the Mannheim Medical Faculty of the University of Heidelberg have released data on an antibody they created that blocks a receptor that stimulates the formation of new blood vessels in tumors and metastasis. Findings from the new stud—published recently in EMBO Molecular Medicine through an article entitled “Preclinical validation of a novel metastasis‐inhibiting Tie1 function‐blocking antibody”—s...

Read More
news image

CELL AND GENE THERAPY

MISSION BIO DEVELOPS SINGLE-CELL SOLUTION TO ADDRESS CHALLENGES IN GENOME EDITING

PR Newswire | May 12, 2023

Mission Bio, the single-cell DNA and multi-omics company, announced today the Tapestri® Genome Editing Solution, an end-to-end product for genome editing analysis. The product will be previewed next week at the American Society of Gene and Cell Therapy Conference (ASGCT) 26th Annual Meeting. By enabling robust single-cell insights impacting both efficacy and safety, the solution will be a powerful analytical tool for developing the next generation of gene-edited therapies. T...

Read More
news image

DIAGNOSTICS

MERIDIAN LAUNCHES NEW QPCR MASTER MIXES FOR STOOL SAMPLES TO ACCELERATE DEVELOPMENT OF MOLECULAR ASSAYS

Meridian | June 21, 2022

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today two new sample-specific master mixes, Lyo-Ready™ Direct DNA qPCR Stool Mix, and Lyo-Ready™ Direct RNA/DNA qPCR Stool Mix. These innovative master mixes improve the molecular detection of DNA and RNA from crude fecal specimens while allowing room temperature stabilization of diagnostic assays. Stool samples are used in many ...

Read More
news image

INDUSTRY OUTLOOK

ANDELYN BIOSCIENCES SELECTS TETRASCIENCE AS A STRATEGIC PARTNER FOR INNOVATION IN THERAPEUTICS DEVELOPMENT AND MANUFACTURING

Andelyn Biosciences | August 26, 2021

TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers. As part of an Andelyn Biosciences initiative to create a Connected Plant that harmonizes data from building and facilities, process and manufacturing, and lab instrument sources, TDP will enable better compliance, easier analysis, faster decisions, and more agile operations. Additio...

Read More